All Industries

Top Therapeutics Companies

205 Therapeutics companies, sorted by total funding raised.

Akari TherapeuticsIPO

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

London, United Kingdom1–10Antibody-Drug Conjugates, Biopharmaceutical
Venture Round·$14.6M·Dec 2025
Parcel Biosciences

Developer of programmable mRNA delivery technology to diverse cell types in the body; next-genera...

San Francisco, United States1–10Biotech, Drug Discovery
Seed·$13.5M·May 2026
ModuLight

Revolutionising the treatment of severe neurological conditions

Boston, Israel11–50Biotech, Medical
Seed·$12.2M·Nov 2025
Valink Therapeutics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Boston, United States11–50Biotech, Drug Discovery
Pre-seed·$11.8M·Oct 2025
Rejuvenation Technologies Inc.

We extend telomeres to extend the human health span

Mountain View, United States1–10Biotech, Healthcare
Seed·$10.6M·Sep 2023
SepracorAcquired

Bioactive membranes and other separation technologies for the chemical processing and pharmaceuti...

Marlborough, United States501–1000Drug Discovery, Healthcare
Venture Round·$10.5M·Jun 1993
Sixfold Bioscience

Delivering RNA therapies.

London, United Kingdom11–50Biotech, Drug Discovery
Seed·$10.5M·Dec 2021
Swing Therapeutics

Develops FDA-cleared prescription digital therapies for chronic illness, including Stanza for fib...

United States11–50Digital Health, Healthcare
Series A·$10.3M·Jun 2022
WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Paris, France11–50Artificial Intelligence, Genomics
Series A·$10.0M·Sep 2022
Arpelos Biosciences

Develops multivalent biologic therapeutics to achieve high potency and selectivity for targeted d...

Cambridge, United States1–10Biotech, Life Sciences
Seed·$9.5M
Andson Biotech

Empowering Mass Spec for Biotech and Beyond

Atlanta, United States1–10Biotech, Deep Tech
Series A·$8.3M·Oct 2025
Relevium Medical

Platform injectable gel based therapeutic for osteoarthritis

Galway, Ireland1–10Drug Discovery, Healthcare
Grant·$7.3M·Nov 2024
TenSixty Bio

Uses AI, cell models, and high-throughput assays to identify antibody targets and develop oncolog...

Cambridge, United States1–10Life Sciences, Artificial Intelligence
Series A·$7.2M·Aug 2022
Granza Bio

Advancing Therapeutic Delivery

San Francisco, United States1–10Biotech, Healthcare
Seed·$7.1M·Jul 2024
Eigen Therapeutics

Develops ML-driven priming co-therapies and a discovery platform to improve targeted cancer treat...

Redwood City, United States1–10Biotech, Drug Discovery
Seed·$7.0M·Dec 2022
LEAH Labs

Living therapies for pets first, and their people next

Minneapolis, United States1–10Drug Discovery, Healthcare
Grant·$5.8M·Aug 2025
Sensible Biotechnologies

Unlocking the next generation of mRNA medicines

Oxford, United Kingdom11–50Biotech, Healthcare
Pre-seed·$4.2M·Apr 2023
Persist AI

Developing long-lasting drug formulations 50% faster

Woodland, United States1–10Artificial Intelligence, Biotech
Seed·$4.0M·Aug 2023
Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

St. John's, Canada51–200Drug Discovery, Genomics
Seed·$3.9M·Aug 2016
Agilis

Provides a SaaS platform that digitizes and structures product data for chemical suppliers, enabl...

Newark, United States51–200E-Commerce, Biotech
Seed·$3.8M
Yemaachi Biotechnology

Diversifying precision cancer diagnostics and treatments

Accra, Ghana11–50Biotech, Diagnostics
Seed·$3.0M·Mar 2022
Catena Biosciences

Using protein coupling to build new therapies

Berkeley, United States1–10Biotech, Healthcare
Seed·$2.4M·May 2024
Alixia

Targeting the Tumor Ecosystem to address cancer drug resistance.

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$2.1M·Jul 2024
SANSIMEON INC

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

WILMINGTON, United States1–10Biotech, Drug Discovery
Funding undisclosed
MYOGENICA INC.

R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.

SAINT PAUL, United States1–10Biotech, Regenerative Medicine
Funding undisclosed